
Bioorganic and Medicinal Chemistry Letters p. 3631 - 3636 (1998)
Update date:2022-08-05
Topics:
Baker, Christopher T.
Salituro, Francesco G.
Court, John J.
Deininger, David D.
Kim, Eunice E.
Li, Biquin
Novak, Perry M.
Rao, Bhisetti G.
Pazhanisamy
Schairer, Wayne C.
Tung, Roger D.
A combination of structure-based design and both solution, and solid- phase synthesis were utilized to derive a potent (nM) series of HIV-1 protease inhibitors bearing a structurally novel backbone. Detailed structural analysis of several inhibitors prepared in this series has suggested that rigidification of the P1/P2 region of this class of molecules may result in compounds with improved potency.
View MoreTianjin Crest Pharmaceutical R&D Co., Ltd. (Tianjin Yao Technology Development Co., Ltd.)(expird)
Contact:+86-22-66211386
Address:Building B5-405, No, 80 4th Avenue, TEDA, Tianjin, China P.R. 300457
Contact:86-513-84128750/13773795976
Address:No.48.Youyi West Road ,Rudong Development Zone,Jiangsu Province,China
Chengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
Shanghai Yuantai Chemical Products Co., Ltd
Contact:021--66129803
Address:Chengyin Road,Shanghai,China
Doi:10.1021/ic9701930
(1997)Doi:10.1007/BF00516199
(1983)Doi:10.1021/jo062140i
(2007)Doi:10.1007/BF02146609
(1968)Doi:10.1080/00397919708005640
(1997)Doi:10.1016/S0040-4039(97)01513-X
(1997)